Financial News
ScreenPro Provides Update on Business Operations
Toronto, Ontario--(Newsfile Corp. - May 10, 2022) - ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that the Company has administered 29,519 Covid-19 tests in April, an increase of 15% compared to March's Covid testing numbers of 25,517.
With the recent news of Toronto's mayor terminating the Covid-19 emergency declaration that was put in place at the beginning of the pandemic in March 2020 and the surge of cases with the new omicron subvariants world-wide, the Company is confident that Covid testing numbers and market share will continue to increase significantly as testing demand is growing each month within the community.
"We are pleased that our core business in Covid testing remains strong with an increase of sales in April. As infections continue to trend upwards, we foresee our testing sales to increase further. Management would also like to address the recent news of the SAG AFTRA amendment to stop testing for Zone C (office) and Zone D (postproduction). This news in the film and production industry has minimal effect on our Covid testing business as majority of the testing we administer has been and continues to be for Zone A (cast) and Zone B (crew)," said Lena Kozovski, CEO of the Company.
About ScreenPro
ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Lena Kozovski, CEO
Email: investors@screenprosecurity.com
Forward-Looking Statements:
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding the acquisition and business of Concierge Medical Consultants Inc. and the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
###
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/123314
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.